What is the competitive landscape for FRESENIUS KABI, and when can generic versions of FRESENIUS KABI drugs launch?
has two hundred and thirty-three approved drugs.
There are thirteen US patents protecting FRESENIUS KABI drugs and there have been four Paragraph IV challenges on FRESENIUS KABI drugs in the past three years. There are two tentative approvals on FRESENIUS KABI drugs.
There are one hundred and seven patent family members
on FRESENIUS KABI drugs in twenty-four countries and two hundred and twenty-four supplementary protection certificates
in twelve countries.